Similarly, in the myeloid blast crisis of CML, the most common mutations occur at the loci of the TP53 tumor suppressor gene (20%–30% cases) and the runt-related transcription factor gene (RUNX1, 38% of cases). This evidence concerns the gene RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive.